Krebs Biochem

33
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
57.34
0.62 (1.09%)
BSENSE

Nov 20

BSE+NSE Vol: 2.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025

Compare Profit and Loss Results of Krebs Biochem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
23.00
105.00
-82.00
-78.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
23.00
105.00
-82.00
-78.10%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-11.00
11.00
100.00%
Raw Materials Consumed
0.00
88.00
-88.00
-100.00%
Power & Fuel Cost
9.00
5.00
4.00
80.00%
Employee Cost
10.00
5.00
5.00
100.00%
Operating Expenses
2.00
2.00
0.00
0.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
3.00
-1.00
-33.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
29.00
95.00
-66.00
-69.47%
Operating Profit (PBDIT) excl Other Income
-5.00
10.00
-15.00
-150.00%
Other Income
2.00
0.00
2.00
0%
Operating Profit (PBDIT)
-3.00
11.00
-14.00
-127.27%
Interest
7.00
3.00
4.00
133.33%
Profit before Depriciation and Tax
-10.00
7.00
-17.00
-242.86%
Depreciation
6.00
2.00
4.00
200.00%
Profit Before Taxation & Exceptional Items
-16.00
4.00
-20.00
-500.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-16.00
5.00
-21.00
-420.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-16.00
4.00
-20.00
-500.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-297.00
24.00
-321.00
-1,337.50%
Profit Available for appropriations
-314.00
28.00
-342.00
-1,221.43%
Appropriations
-314.00
28.00
-342.00
-1,221.43%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-7.85
5.43
-13.28
-244.57%
Profit And Loss - Net Sales
Net Sales 23.73 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.45 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025

Profit And Loss - Interest
Interest 7.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax -16.93 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025